| Old Articles: <Older 1901-1910 Newer> |
 |
Fast Company November 2005 Michael A. Prospero |
If Popeye Were a Biochemist Spinach is not only good for you, but one day might be good for the environment, too -- in the form of batteries.  |
Smithsonian December 2005 Will Rizzo |
Phenomena and Curiosities: Return of the Jaguar Novel camera traps have documented the elusive cat in Arizona, suggesting it may not be gone from the United States after all.  |
Smithsonian December 2005 Lawrence M. Small |
A Whale Called Phoenix A very large mammal will help tell an even weightier tale -- about the ocean in this crowded, challenging century.  |
BusinessWeek November 28, 2005 John Carey |
Avian Flu: Business Thinks The Unthinkable Experts say most companies don't yet realize how serious the economic effects of a pandemic could be. But some executives are starting to confront the real chance of panicked workers, supply disruptions, and economic upheaval.  |
BusinessWeek November 28, 2005 Arlene Weintraub |
My, How You've Grown A wave of drugs for short kids is sparking social controversy -- and an expanding market. Growth hormones are likely to remain in the spotlight for another reason: They could become the first-ever biotech drugs to become available in generic form.  |
BusinessWeek November 28, 2005 John Carey |
Prevent A Pandemic, Make A Profit Where there's disaster, there's opportunity for business.  |
BusinessWeek November 28, 2005 Chester Dawson |
A Recliner That Goes 40 KPH The environmentally friendly, battery-powered i-unit turns heads anywhere it goes. But will Toyota mass-produce it?  |
BusinessWeek November 28, 2005 Arlene Weintraub |
Human Growth Hormone: Unproven and Unsafe HGH is often hyped as a cure for aging. But as so with most fountains of youth, there's no proof that it works. And it can be harmful. But for now, off-label use of human growth hormone appears to be a growth industry.  |
HBS Working Knowledge November 21, 2005 Sean Silverthorne |
The Geography of Corporate Giving Why do companies support nonprofits and other socially responsible activities when there is no clear-cut evidence that corporate "do-gooding" results in greater returns for shareholders?  |
Scientific American November 21, 2005 JR Minkel |
Trials for the Poor Researchers hope randomized trials will help develop better antipoverty programs.  |
| <Older 1901-1910 Newer> Return to current articles. |